Literature DB >> 7959193

Clinical courses and predictors for rebleeding in patients with peptic ulcers and non-bleeding visible vessels: a prospective study.

H J Lin1, C L Perng, F Y Lee, C H Lee, S D Lee.   

Abstract

Detailed characterisation of non-bleeding visible vessels in terms of colour, size evolution, and time of rebleeding is important in determining the natural history of these lesions. The colour and size of non-bleeding visible vessels were observed endoscopically every day for three days and then every other day until rebleeding or flattening of visible vessels occurred in 140 patients. Rebleeding happened in 61 (44%) patients. Of them, 59 (97%) rebled within 72 hours. Flattening of visible vessels happened in 79 (56%) patients and 77 of 79 (98%) had flattening of visible vessels within 72 hours. Rebleeding rate increased with increasing length of exposed vessels (r = 0.96, p < 0.001). Coffee ground fluid or blood retention in the stomach and ulcer size > or = 2.0 cm were independent predictors for rebleeding using multivariate analysis. It is suggested that patients with non-bleeding visible vessels and independent predictors for rebleeding may need early aggressive treatment.

Entities:  

Mesh:

Year:  1994        PMID: 7959193      PMCID: PMC1375011          DOI: 10.1136/gut.35.10.1389

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  38 in total

1.  High gastric ulcer.

Authors:  H E Jensen; J Hoffmann; P Wille-Jørgensen
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

2.  Controlled trial of endoscopic sclerosis in bleeding peptic ulcers.

Authors:  J Panés; J Viver; M Forné; E Garcia-Olivares; C Marco; J Garau
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

3.  The value of emergency endoscopy in upper gastrointestinal bleeding: review and analysis of 2014 cases.

Authors:  W Domschke; P Lederer; G Lux
Journal:  Endoscopy       Date:  1983-05       Impact factor: 10.093

4.  The national ASGE survey on upper gastrointestinal bleeding. III. Endoscopy in upper gastrointestinal bleeding.

Authors:  D A Gilbert; F E Silverstein; F J Tedesco; N K Buenger; J Persing
Journal:  Gastrointest Endosc       Date:  1981-05       Impact factor: 9.427

5.  A study of the factors influencing mortality rates from gastrointestinal haemorrhage.

Authors:  R Allan; P Dykes
Journal:  Q J Med       Date:  1976-10

6.  Factors predisposing to recurrent haemorrhage after acute gastrointestinal bleeding.

Authors:  T C Northfield
Journal:  Br Med J       Date:  1971-01-02

7.  Etiology and prevalence of severe persistent upper gastrointestinal bleeding.

Authors:  D Fleischer
Journal:  Gastroenterology       Date:  1983-03       Impact factor: 22.682

8.  Multipolar electrocoagulation in the treatment of active upper gastrointestinal tract hemorrhage. A prospective controlled trial.

Authors:  L Laine
Journal:  N Engl J Med       Date:  1987-06-25       Impact factor: 91.245

9.  Importance of hypovolaemic shock and endoscopic signs in predicting recurrent haemorrhage from peptic ulceration: a prospective evaluation.

Authors:  P C Bornman; N A Theodorou; R D Shuttleworth; H P Essel; I N Marks
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-27

10.  Further haemorrhage after admission to hospital for gastrointestinal haemorrhage.

Authors:  P F Jones; S J Johnston; A B McEwan; J Kyle; C D Needham
Journal:  Br Med J       Date:  1973-09-29
View more
  14 in total

Review 1.  Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: a systematic review.

Authors:  Sara El Ouali; Alan Barkun; Myriam Martel; Davide Maggio
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

2.  Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting.

Authors:  Robert-A Enns; Yves-M Gagnon; Alan-N Barkun; David Armstrong; Jamie-C Gregor; Richard-N Fedorak
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  Endoscopic hemoclip treatment for bleeding peptic ulcer.

Authors:  Yung-Chih Lai; Sien-Sing Yang; Chi-Hwa Wu; Tzen-Kwan Chen
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

4.  Application of endoscopic hemoclips for nonvariceal bleeding in the upper gastrointestinal tract.

Authors:  Shi-Bin Guo; Ai-Xia Gong; Jing Leng; Jing Ma; Lin-Mei Ge
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

Review 5.  Upper gastrointestinal bleeding risk scores: Who, when and why?

Authors:  Sara Monteiro; Tiago Cúrdia Gonçalves; Joana Magalhães; José Cotter
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

6.  Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy.

Authors:  Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Kee Tae Park; Gwang Ha Kim; Geun Am Song; Mong Cho
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

7.  Risk Factors Associated with Rebleeding in Patients with High Risk Peptic Ulcer Bleeding: Focusing on the Role of Second Look Endoscopy.

Authors:  Sung Bum Kim; Si Hyung Lee; Kyeong Ok Kim; Byung Ik Jang; Tae Nyeun Kim; Seong Woo Jeon; Joong Goo Kwon; Eun Young Kim; Jin Tae Jung; Kyung Sik Park; Kwang Bum Cho; Eun Soo Kim; Hyun Jin Kim; Chang Keun Park; Jeong Bae Park; Chang Heon Yang
Journal:  Dig Dis Sci       Date:  2015-08-22       Impact factor: 3.199

8.  Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits.

Authors:  Hsiu-Chi Cheng; Bor-Shyang Sheu
Journal:  World J Gastrointest Endosc       Date:  2011-03-16

Review 9.  Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis.

Authors:  Patrick Yachimski; Chin Hur
Journal:  Dig Dis Sci       Date:  2008-07-26       Impact factor: 3.199

10.  Risk factors for mortality in severe upper gastrointestinal bleeding.

Authors:  Frank Klebl; Nicole Bregenzer; Lars Schöfer; Wolfgang Tamme; Julia Langgartner; Jürgen Schölmerich; Helmut Messmann
Journal:  Int J Colorectal Dis       Date:  2004-08-19       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.